Literature DB >> 6934544

Cord-blood tyrosine levels in the full-term phenylketonuric fetus and the "justification hypothesis".

C R Scriver, D E Cole, S A Houghton, H L Levy, A Grenier, C Laberge.   

Abstract

The "justification hypothesis" attributes mental retardation in phenylketonuria (PKU) to an inability of the heterozygous mother to deliver an appropriate amount of tyrosine to the PKU fetus who, in turn, is unable to correct for this deficiency because of its genetic constitution. We tested this hypothesis by measuring concentrations of tyrosine and phenylalanine in cord blood obtained at delivery from nine infants with PKU and five infants with persistent (non-PKU) hyperphenylalaninemia (PHP). For each of these specimens there were four control cord-blood specimens from infants born on the same day and, generally, in the same hospital. PKU and PHP groups were similar with respect to cord-blood tyrosine and phenylalanine values. There was no biologically significant deficiency of tyrosine in cord blood of the pooled PKU and PHP deficiency of tyrosine in cord blood of the pooled PKU and PHP groups (54 +/- 10 microM, mean +/- SD) compared with controls (61 +/- 16 microM, P = 0.13). On the other hand, phenylalanine in cord blood of the pooled PKU and PHP groups was significantly increased (144 +/- 30 microM, mean +/- SD) compared with controls (128 +/- 24, P = 0.004). The mangitude of the differences in cord-blood tyrosine and phenylalanine between control and PKU subjects are so small that it is unlikely that they have any consequences for physical and mental development. The justification hypothesis, as it pertains to blood tyrosine at term, is not upheld.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6934544      PMCID: PMC350237          DOI: 10.1073/pnas.77.10.6175

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Serum amino acid concentrations during pregnancy of women heterozygous for phenylketonuria.

Authors:  H K Berry; I B Poncet; B S Sutherland; R Burkett
Journal:  Biol Neonate       Date:  1975

2.  Intellectual performance of 36 phenylketonuria patients and their nonaffected siblings.

Authors:  J C Dobson; E Kushida; M Williamson; E G Friedman
Journal:  Pediatrics       Date:  1976-07       Impact factor: 7.124

Review 3.  Genetic screening.

Authors:  H L Levy
Journal:  Adv Hum Genet       Date:  1973

4.  A modified automated fluorometric method for tyrosine determination in blood spotted on paper: a mass screening procedure for tyrosinemia.

Authors:  A Grenier; C Laberge
Journal:  Clin Chim Acta       Date:  1974-11-20       Impact factor: 3.786

5.  Birthweights in children with phenylketonuria and in their siblings.

Authors:  L F Saugstad
Journal:  Lancet       Date:  1972-04-15       Impact factor: 79.321

6.  Classic phenylketonuria: heterozygote detection during pregnancy.

Authors:  R F Griffin; M E Humienny; E C Hall; L J Elsas
Journal:  Am J Hum Genet       Date:  1973-11       Impact factor: 11.025

7.  Genetic failure of fetal amino acid "justification": a common basis for many forms of metabolic, nutritional, and "nonspecific" mental retardation.

Authors:  S P Bessman
Journal:  J Pediatr       Date:  1972-10       Impact factor: 4.406

8.  Intelligence quotients and intelligence loss in patients with phenylketonuria and some variant states.

Authors:  J L Berman; R Ford
Journal:  J Pediatr       Date:  1970-11       Impact factor: 4.406

9.  Treated phenylketonuria: intelligence and blood phenylalanine levels.

Authors:  R Fuller; J Shuman
Journal:  Am J Ment Defic       Date:  1971-03

10.  Termination of restricted diet in children with phenylketonuria: a randomized controlled study.

Authors:  N A Holtzman; D W Welcher; E D Mellits
Journal:  N Engl J Med       Date:  1975-11-27       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.